The current health expenditure in India, measured in US Dollars PPP per capita, showed forecasted values with consistent growth from 2024 to 2028, starting at $207.33 in 2024 and reaching $219.82 in 2028. This upward trend indicates a steady increase in healthcare investments.
For the year-on-year variation in percentage:- 2025 saw a 1.58% increase from 2024.- 2026 observed a 1.50% rise from 2025.- 2027 recorded a 1.44% growth from 2026.- 2028 exhibited a 1.37% enhancement from 2027. The CAGR (Compound Annual Growth Rate) for the forecasted period is approximately 1.48%, demonstrating a consistent annual increase in health expenditure per capita over the next five years.
Future trends to watch for include the increasing impact of technology and digital health initiatives, the role of government policies and funding, and the potential effects of demographic shifts and disease prevalence on healthcare expenditure.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
